Adverum Clinical Site 240 — Bloomfield, New Jersey

Adverum Clinical Site 240 is a clinical research site located in Bloomfield, New Jersey, United States 07003.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Adverum Clinical Site 240 has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Neovascular Age-Related Macular Degeneration (nAMD), Wet AMD.

Sponsors: Adverum Biotechnologies, Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Bloomfield

Browse all research sites in New Jersey · View every site in Bloomfield

• Montclair State University
• Envision Ocular LLC
• Retina Center of New Jersey
• The Retina Center of New Jersey
• Bloomfield, NJ
• Retina Center of NJ, LLC
• Regeneron Study Site
• Retina Center of New Jersey, LLC
• Bloomfield, New Jersey
• Immedicenter
• GSK Investigational Site
• Novartis Investigative Site

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Adverum Clinical Site 240?

Adverum Clinical Site 240 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Adverum Clinical Site 240 conducted?

Adverum Clinical Site 240 has 1 clinical trials on record, with 1 currently active. Their work covers Neovascular Age-Related Macular Degeneration (nAMD), Wet AMD.

Is Adverum Clinical Site 240 accredited by Crixeo Clinical Trials?

Adverum Clinical Site 240 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Adverum Clinical Site 240?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.